5 documents found, page 1 of 1
Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disea...
Yoo, SGK; Chung, GS; Bahendeka, SK; Sibai, AM; Damasceno, A; Farzadfar, F; Rohloff, P; Houehanou, C; Norov, B; Karki, KB; Azangoukhyavy, M; Marcus, METhe role of aspirin in the primary prevention of atherosclerotic cardiovascular disease (CVD) is not clear, with recent clinical trials evaluating aspirin for primary prevention demonstrating both modest benefits and risks associated with its use [1]. Aspirin is not routinely recommended for primary prevention of CVD. Understanding patterns of aspirin use can inform strategies to promote guideline-concordant th...
Diagnostic testing for hypertension, diabetes, and hypercholesterolaemia in low...
Ochmann, S; von Polenz, I; Marcus, ME; Theilmann, M; Flood, D; Agoudavi, K; Aryal, KK; Bahendeka, S; Bicaba, B; Bovet, P; Campos Caldeira Brant, LBackground Testing for the risk factors of cardiovascular disease, which include hypertension, diabetes, and hypercholesterolaemia, is important for timely and effective risk management. Yet few studies have quantified and analysed testing of cardiovascular risk factors in low-income and middle-income countries (LMICs) with respect to sociodemographic inequalities. We aimed to address this knowledge gap. Method...
Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-,...
Yoo, SGK; Chung, GS; Bahendeka, SK; Sibai, AM; Damasceno, A; Farzadfar, F; Rohloff, P; Houehanou, C; Norov, B; Karki, KB; Azangou-Khyavy, M; Marcus, ME"Importance Aspirin is an effective and low-cost option for reducing atherosclerotic cardiovascular disease (CVD) events and improving mortality rates among individuals with established CVD. To guide efforts to mitigate the global CVD burden, there is a need to understand current levels of aspirin use for secondary prevention of CVD. Objective To report and evaluate aspirin use for secondary prevention of CVD a...
The Association of Socioeconomic Status With Hypertension in 76 Low- and Middle...
Kirschbaum, TK; Sudharsanan, N; Manne Goehler, J; De Neve, JW; Lemp, JM; Theilmann, M; Marcus, ME; Ebert, C; Chen, SM; Yoosefi, M; Sibai, AMBackground Effective equity-focused health policy for hypertension in low- and middle-income countries (LMICs) requires an understanding of the condition’s current socioeconomic gradients and how these are likely to change in the future as countries develop economically. Objectives This cross-sectional study aimed to determine how hypertension prevalence in LMICs varies by individuals’ education and household w...
Data Resource Profile: The Global Health and Population Project on Access to Ca...
Manne-Goehler, J; Theilmann, M; Flood, D; Marcus, ME; Andall-Brereton, G; Agoudavi, K; Lopez Arboleda, WA; Aryal, KK; Bicaba, B; Bovet, P[No abstract available]